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Abstract
Background: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have
shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of
control into everyday clinical practice can be difficult. Intensive improvement programs are successful in attaining control
in patients with type 2 diabetes, however, many patients experience glycemic relapse once returned to routine care. This
early relapse is, in part, due to decreased adherence in self-management behaviors.
Objective: This paper describes the design of the Glycemic Relapse Prevention study. The purpose of this study is to
determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse. The primary endpoint
is glycemic relapse, which is defined as glycated hemoglobin greater than 8% and an increase of 1% from baseline.
Methods: The intervention consists of telephonic contact by a nurse practitioner with a referral to a dietitian if
indicated. This intervention was designed to provide early identification of self-care problems, understanding the
rationale behind the self-care lapse and problem solve to find a negotiated solution. A total of 164 patients were
randomized to routine care (least intensive), routine care with phone contact every three months (moderate intensity)
or routine care with phone contact every month (most intensive).
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Conclusion: The baseline patient characteristics are similar across the treatment arms. Intervention fidelity analysis
showed excellent reproducibility. This study will provide insight into the important but poorly understood area of
glycemic relapse prevention.
Background
Diabetes is a common disease and has great impact on the
individual and society[1]. The burden of diabetes is
expected to increase as the population ages, becomes
more ethnically diverse and more obese[2]. Self-manage-
ment of diabetes is critical to prevent the complications
associated with diabetes and, yet, remains difficult for
many patients to sustain.
Recent large randomized controlled trials have proven
that tight glycemic control reduces the microvascular and
macrovascular complications of diabetes [3-5]. Reduction
of these complications also leads to a great cost savings to
healthcare and society[6]. However, it has been difficult to
translate the success of these large randomized control tri-
als to everyday practice [7-9]. A recent cross-sectional
analysis of 95 clinicians revealed only 40.5% of type 2 dia-
betes patients had a glycated hemoglobin (HbA1c) less
than 7%[9]. Even large, well-conducted, multi-factorial
randomized controlled trials aimed at reducing HbA1c
have not had success in maintaining long-term glycemic
control[10]. The disparity of care between the large trials
and a primary care office is largely due to the difference in
resources available in the typical medical office. Practical,
sustainable ways of maintaining tight glycemic control are
needed in everyday practice. Indeed, a number of for
profit corporations have entered this arena of disease
management given a seeming inability of the current clin-
ical milieu to adequately address this issue.
While diabetes improvement programs are successful in
acutely lowering HbA1c [11-24] the long-term effective-
ness of these programs is disappointing. Approximately
40% of those who return to routine care after completing
an intensive diabetes improvement program experience a
relapse in their glycemic control within one year [25-27].
While some of the glycemic relapse may represent a natu-
ral progression of the underlying disease, it is unlikely that
such a high percentage would experience such significant
disease progression in such a short period of time[4,28].
Some proportion of the relapse is likely due to a patient's
inability to maintain adherence to key self-care behaviors
– diet, exercise, self-monitoring of blood glucose and
medication regimen. Little is known about the optimal
frequency, intensity or nature of maintenance interven-
tions needed to prevent deterioration of self-care behav-
iors that lead to glycemic relapse.
Hypothesis
The purpose of this study is to better understand preven-
tion of glycemic relapse. The primary aim of this study is
to assess the relative effectiveness of three management
approaches, varying in frequency, for preventing glycemic
relapse after glycemic control has been achieved through
participation in an intensive diabetes improvement pro-
gram. This study will determine the optimal frequency of
intervention needed to prevent glycemic relapse in
patients with type 2 diabetes. The authors hypothesize
that high intensity intervention will lead to a decrease in
glycemic relapse in a dose dependent fashion.
Other aims to be addressed in this study include determi-
nation of patient characteristics and behaviors predictive
of glycemic relapse. In doing so, specific subgroups in
need of alternative maintenance strategies will also be
identified. Finally, this study will also determine the dif-
ferences in activity cost between the intervention arms
using activity based accounting.
Methods
Study Design
This study is a prospective, randomized control trial to
assess the relative effectiveness of three management strat-
egies for the purpose of preventing glycemic relapse in
type 2 diabetes. The subjects will be randomized to one of
three arms: routine follow-up in a primary care clinic
(control), telephone contact every three months (moder-
ate intensity) or telephone contact every month (high
intensity). The duration of the study is 24 months. At the
completion of the intervention period, the subjects will be
asked to complete another 12 months of follow-up during
which everyone will receive routine care only. The pri-
mary endpoint is glycemic relapse. Glycemic relapse is
defined as a HbA1c greater than 8% and an increase by
1% point from baseline. The primary analysis will be
based on intention to treat.
Study Setting
Telephonic intervention based out of an academic center
in middle Tennessee. At recruitment, study participants
lived in the city and surrounding suburbs of the academic
center.
Study Population
All subjects are recruited after completion of a 12 week
outpatient, intensive diabetes improvement program fol-
lowing referral for poor glycemic control (HbA1c>8%).Implementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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The intensive improvement program consists of instruc-
tion and support in diabetes self-management coupled
with intensification of glycemic medications, including
insulin. It is provided by nurse practitioners and super-
vised by a practicing diabetologist. The educational con-
tent includes diet, exercise, self-monitoring of blood
glucose and medication adherence as well as instruction
in preventive measures such as foot care and screening for
complications. Upon completion of the program, only
those subjects referred to the improvement program for
poor glycemic control (HbA1c>8%) and who obtained
control (HbA1c<8% and at least an absolute 1% decline
in HbA1c) during the program were recruited. Only sub-
jects aged 18–75 years of age were included. Pregnant
women were excluded.
Randomization
Two weeks after completion of the improvement pro-
gram, a research assistant contacted patients and gave
them a brief explanation of the study. The subjects were
then invited to participate in the study if they met the
defined inclusion criteria. A research assistant confirmed
eligibility. After informed consent was obtained, patients
were randomly assigned to one of three study arms. Ran-
domization applied permuted block scheme for balanc-
ing interval, varying randomly among 3, 6, 9 and12
according to the outcome of a computer generated ran-
dom number. This ensured that the cumulative number of
assignments to each treatment would be in balance after
each block of assignments had been made. The allocation
sequence was written by the statistician involved with the
trial. Once treatment arm status was assigned by the
research assistant, subjects in the intervention arms were
assigned a study nurse practitioner. Due to the nature of
this intervention, blinding of participants, investigators
and study nurse practitioners was not possible. See Figure
1 for enrollment and randomization scheme.
Intervention
The intervention consists of a phone contact by a nurse
practitioner with a referral to a dietitian if nutrition self-
care is perturbed. The characteristics of the intervention
are described in Table 1 using a diabetes intervention tax-
onomy previously characterized[29] The duration of each
contact was monitored. During the first session, shared
goal setting was established and referred to or modified
during subsequent contacts. The method and content of
the phone contacts varied based on the assessment. If
there were no problems related to glycemic control or self-
care behaviors identified, then Protocol 1 was followed
(see Figure 2). If a problem was identified, Protocol 2 was
followed (see Figure 2). The intervention does not vary
between the treatment arms; only the frequency of the
intervention varies.
Protocol 1 is characterized by anticipatory planning for
potential lapses, including practicing a coping skill, and
also offers self-efficacy enhancement through positive
reinforcement, short-term goal setting and cognitive
rewards. If a self-care problem was identified then proto-
col 2 was followed. The subject was asked to identify the
source of the struggle. If readily identified, the interviewer
employed a 5 step problem solving paradigm: 1) Define
problem clearly, 2) Brainstorm strategies, 3) Choose a
strategy, 4) Develop an action plan and 5) Try it and revise
as needed. If a subject was unable to identify a reason for
deteriorating self-care behavior, motivational interview-
ing was employed largely as a diagnostic modality[30]
Subjects were asked to assess the importance of and their
confidence in correcting the lapse behavior. The individ-
Table 1: Intervention Structure
Setting One-on-One
Delivery Phone contact
Teaching Methods Shared goal setting
Problem solving
Cognitive re-framing
Diaries
Content Diet
Exercise
Self-monitoring of blood glucose
Medication management
Provider Diabetes certified nurse educator with a dietician referral if diet self-care is perturbed
Tailoring of intervention to an assessment Yes
Modification of intervention with follow-up Yes
Intensity of intervention
Number of episodes Arm 2: 8
Arm 3: 24
Duration of episodes Measured as part of study protocol
Duration of study 24 months
Initial supplement given NoImplementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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ual was then asked to comment on what prevented them
from giving a higher importance/confidence score. This
often identified an underlying problem which led back to
the problem solving paradigm. In addition to providing a
diagnostic tool for identification of the reasons behind
the lapse, the motivational interview may also provide a
cue to action via the subject's reflection during the assess-
ment.
The interviewer worked with the subject to correct (e.g.
correcting a cognitive distortion) the underlying reason
for the perturbation of the self-care behavior. If the obsta-
cle could not be corrected (i.e. divorce, financial barrier),
then the interviewer worked with the subject to develop a
coping mechanism. However, if the subject remained
unable to identify a reason for lapse in self-care behavior
or to devise a coping strategy, the interviewer worked with
the subject to negotiate a change in another self-care
behavior as a compensation for the perturbed behavior. A
negotiated compensation, for example, may include
increased exercise, increased monitoring or increased
insulin use for a perturbation of diet self-care.
Intervention Fidelity
To enhance the reliability and validity of the behavioral
intervention portion of this study, intervention fidelity
tools were used to monitor the phone contacts between
the nurse practitioners and the study subjects [31-33]. The
analysis consisted of qualitative descriptions of the extent
to which a sample of intervention phone calls was consist-
ent with the intervention protocol (Figure 2) and guide-
lines. Consistency between the nurse practitioners was
also determined. Raters used checklists derived from the
protocols to document which elements were conducted or
omitted. Overall, adherence to the protocol was quite
high with almost all elements present in more than 80%
of all interviews. The educators did not differ significantly
in any category.
Enrollment and Randomization Figure 1
Enrollment and Randomization.
Subjects with poor glycemic control in 
the primary care setting (HbA1c>8%)
Subjects that complete the intensive 
diabetes improvement program,
Contacted if HbA1c < 8%
n = 315
Agreed to participate,
n = 169
Arm 1: Routine primary care 
(control – least intense)
n=54
Arm 2: Routine care plus every 3 month 
phone contact (moderate intensity) 
n=55
Arm 3: Routine care plus every month 
phone contact (most intense)
n=55
Referral
Not reached, n = 79
Ineligible due to relapse, n = 4
Declined participation
n = 67
Consented and randomized
n = 165
Inappropriately randomized
n=1
Inconvenient
(distance/work/language)
n=19
Too many appointments
n=8
Not enough time to participate
n=11
Not interested
n=29Implementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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Primary Outcome
The primary outcome is the glycemic relapse rate at 24
months. Relapse is defined as a HbA1c greater than 8%
and an absolute 1% increase from baseline. The HbA1c
will be measured at baseline and at 6-month intervals
throughout the study.
Secondary Outcomes
Activity Assessment
A pager-sized (2.8 × 2.2 × 1.1 inches, weighing 2.3 oz) tri-
axial portable accelerometer (RT3 Research Activity
Tracker by StayHealthy, Inc. Monrovia CA) is used to
measure detailed movements in the center of body mass
(worn at the hip). The RT3 monitor is programmed with
each study participant's weight, height, age, and gender
prior to application. During each of the visits, each subject
is fitted with the RT3 monitor securely on his/her right
hip, either by direct clipping to the belt or using a small
pouch-bag (for women who do not usually wear a waist
belt). Subjects are instructed to wear the RT3 monitor dur-
ing all possible non-sleeping activities, except during
water sports, for the next 7 days. Once the monitor is ini-
tialized, it runs continuously without interruption from
the subject (no buttons to push). At the end of the 7-day
monitoring period, the RT3 is mailed back to the study
coordinator via a pre-addressed/stamped bubble enve-
lope and its data downloaded. Using the raw activity
counts and a prediction model which was previously
developed and validated[34], the total energy expenditure
and overall physical activity levels during each study
period are obtained for each subject. Furthermore, utiliz-
ing durations of activities within certain intensity catego-
ries (utilizing the minute-to-minute measurements),
subject's adherence to exercise will be validated.
Telephone Contact Intervention Flow Sheet Figure 2
Telephone Contact Intervention Flow Sheet.
Assessment
Inquire about problems with adherence to self-care:
1. Blood glucose monitoring
2. Medication regimen/adherence
3. Diet prescription
4. Exercise regimen
Protocol 1 – No self care problem identified
Anticipatory Planning:
1. Identify high risk situations
2. Practice Coping Skill: suggest either a 
behavioral strategy, such as avoidance, or a 
cognitive strategy, such as positive self-talk.
3. Managing lapses:  Listen to subject’s solutions.  
Reinforce that lapses are an opportunity to learn.  
Remind of the importance of forgiving oneself 
and moving on.
Enhancing Self-Efficacy
1. Provide Positive Reinforcement:  
2. Cognitive Rewards: This allows subject to 
realize the benefits of her/his efforts.
3. Negotiate new small goals:  Help establish new 
concrete, manageable goals.  Follow-up on this 
at next contact.
Protocol 2 - Self-care problem identified
1. Define the problem clearly
2. Brainstorm strategies that 
may be applicable 
3. Choose one
4. Develop an Action Plan
5. Try it.  Revise plan as 
needed.
1. Potentially able to identify 
the barrier and then 
proceed with the problem 
solving paradigm.  
2. Assessment may prompt 
behavior change through 
reflection.
3. If unable to correct barrier 
or devise coping strategy, 
then consider negotiating 
a change in another self-
care behavior as a
temporary compensation.
Conclusions
1. Concluding remarks with positive reinforcement.
2. Reminder for next phone contact
3. Leave phone number for patient to contact staff if necessary.
Barrier identified:
If barrier (e.g., knowledge, skill or 
event) is readily identified, the 
interviewer employs the problem 
solving paradigm to manage
Barrier unclear:
If subject is unable to identify a 
barrier, the interviewer employs 
motivational interviewing as a 
diagnostic agent through 
exploration of importance and 
confidence.Implementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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Depression Score
The Center for Epidemiologic Studies Depression Scale
(CES-D) is used to assess depression in this study. The
CES-D is a well-validated, 20 item self-administered ques-
tionnaire that quantifies the frequency of depressive
symptoms over the previous 7 days. Four items are
reversed scored and the total possible score is 60 with 0–
9 representing no to minimal symptoms, 10–16 mild
symptoms, 17–24 moderate symptoms and >24 severe
depressive symptoms.[35]
Cost Accounting Analysis
Cost analysis of the interventions will be assessed using
activity based cost (ABC) accounting techniques[36]. ABC
differs from conventional cost accounting in that ABC
establishes a causal relationship between work per-
formed, the costs thereof, and the clinical outcomes of the
same. In so doing, ABC enables researchers to quantify
more precisely the costs of interventions, the skill level of
the team member performing the task, the sequence of
activities, and the patients' outcomes.
Data Management
Data is entered into MS Access (Microsoft Corporation,
Redmond, WA) tables. Management report generating
programs are used to track subject's progress through the
study and to generate letters when visits are due. This also
allows for early identification of missing data.
Study size
Sample size calculation was performed based on chi-
square test for linear trend in proportions of patients
among the three study arms who relapsed during the
study period (118). We expected 50% of patients who are
assigned to study arm A (routine primary care follow-up)
relapse during the study period, 30% in the study arm B
(scheduled 3 month interaction with a certified nurse),
and 20% in the study arm C (scheduled 1 month interac-
tion with a certified nurse). Anticipating 20% attrition,
165 subjects (55 recruited/44 complete study) will pro-
vide 85% power to detect statistically significant linear
trend at 2-sided 5% alpha level. Calculations for power
analysis were performed by using nQuery Advisor version
4.0 (Statistical Solutions, Stonehill Corporate Center, Sau-
gus, MA).
Ethics
This trial received approval from the Vanderbilt Institu-
tional Review Board. An information sheet was given to
all subjects and those who agreed to participate were con-
sented prior to randomization. Informed consent was
obtained from all subjects. Subjects are free to withdraw
from the study at any time, although they were encour-
aged to decline randomization unless they were prepared
to participate in the study for 24 months. The confidenti-
ality of the study data are maintained as follows: once
computerized, data are not linked to identifying informa-
tion and the original documents are kept in locked cabi-
nets. The computerized records are identified by study
number which is the only link to the subject's identifica-
tion. Access to the identifying information is restricted to
the principal investigator and the study coordinator.
Patients received $50 upon completion of the study.
Population characteristics
Enrollment started June 2002 and concluded in January
2005. A total of 164 subjects completed randomization.
The control group consists of 54 subjects and each of the
intervention arms consists of 55 patients. The baseline
characteristic were similar across the groups, see Table 2,
with no statistically significant differences.
The average age (± SD) of the population was 55 ± 10.7
years. Forty-four percent were female and 20% were Afri-
can-American. The average HbA1c (± SD) was 6.7 ± 0.68
and the average duration of diabetes (± SD) was 7.1 ± 8.2
years. Fifty-four percent used insulin with a median of 55
(IQR 25–92) units/day of insulin. The average BMI (± SD)
was 34 ± 6.9 kg/m2 and the average waist circumference (±
SD) was 42.9 ± 5.8 cm. Results for the CES-D were availa-
ble for 118 subjects and the median CES-D was 9 (IQR 4–
17). The CES-D results were available with equal frequen-
cies in each study arm.
Baseline physical activity data was successfully obtained
in 154 subjects. The baseline measures of daily energy
expenditure, physical activity level (PAL) and time spent
in moderate and vigorous physical activities (MVPA) were
similar in all three groups (see Table 2) and fairly similar
to average sedentary populations.
The initial nurse's assessment for the intervention groups
were similar (see Table 3). The initial assessment occurred
within 2 months of the completion of the intensive out-
patient diabetes improvement program. The average
number of minutes spent on the initial phone contact was
19.6 ± 9.3. Five variables were assessed by the nurses
including glycemic control, self blood glucose monitor-
ing, medication adherence, diet adherence and exercise
adherence. The majority of the patients answered
unchanged in each category for this baseline assessment.
At baseline, 28% had already self-reported worsening of
their glycemic control since completion of the improve-
ment program.
Discussion
This study will advance our understanding of mainte-
nance of glycemic control. The authors approached
relapse prevention in a novel way – by determining the
"dose" of intervention needed to prevent glycemicImplementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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relapse. The intervention is carefully outlined to allow for
reproducibility. Intervention fidelity is excellent. This
study will also compare the cost of the intervention to
routine care. As there is a burgeoning business in chronic
care management, it is important to study chronic care
interventions for both efficacy and cost-effectiveness to
aid in the development of evidence based services.
Table 3: Baseline nurses' assessment
Variable Moderate Intensity Group (n = 55) High Intensity Group (n = 55)
Length of phone call, min 21.0 ± 9.4 18.7 ± 8.9
Glycemic control
Improved 12 (22) 10 (19)
Unchanged 30 (56) 25 (48)
Worse 12 (22) 17 (33)
Self blood glucose monitoring
Improved 3 (6) 1 (2)
Unchanged 43 (81) 39 (74)
Worse 7 (13) 13 (25)
Medication adherence
Improved 1 (2) 1 (2)
Unchanged 46 (87) 45 (85)
Worse 6 (11) 7 (13)
Diet adherence
Improved 9 (18) 8 (15)
Unchanged 33 (65) 34 (64)
Worse 9 (18) 11 (21)
Exercise adherence
Improved 12 (23) 14 (27)
Unchanged 23 (44) 26 (50)
Worse 17 (33) 12 (23)
Reported as mean ± standard deviation or n (%).
Table 2: Baseline population characteristics
Characteristic Control Group (n = 54) Moderate Intensity Group (n = 55) High Intensity Group (n = 55)
Age, yrs 56.2 ± 10 55.7 ± 11 53.5 ± 11
Female, n (%) 23 (43) 21 (38) 28 (51)
African American, n (%) 7 (13) 16 (29) 12 (22)
≥ High School, n (%) 47 (87) 49 (89) 50 (91)
Duration of diabetes, yrs 5.5 (0.7–10) 4.0 (0.5–10) 4.0 (0.5–10)
Insulin use, n (%) 32 (54) 49 (45) 50 (58)
Units of insulin per day 39 (24–79) 59 (32–100) 61 (25–93)
Weight, lbs 225 ± 48 215 ± 37 223 ± 51
BMI 34 ± 7 33 ± 6 35 ± 7
Waist circumference, in 43.5 ± 6.2 41.8 ± 4.8 43.3 ± 6.3
HbA1c 6.7 ± 0.7 6.6 ± 0.7 6.8 ± 0.6
Systolic BP 126 ± 15 125 ± 17 127 ± 15
Diastolic BP 72 ± 9 72 ± 11 73 ± 12
Total cholesterol 177 ± 28 178 ± 35 174 ± 34
HDL 43 ± 13 44 ± 11 41 ± 11
LDL 97 ± 28 97 ± 30 98 ± 31
Triglycerides 185 (124–229) 168 (124–246) 161 (112–219)
CES-D 9 (4–18) 10 (4–17) 7 (4–14)
DEE 3007 ± 671 2963 ± 659 3097 ± 869
PAL 1.31 ± 0.08 1.32 ± 0.08 1.34 ± 0.09
MVPA 62 (35–91) 61 (40–116) 77 (41–126)
Reported as mean ± standard deviation or median (interquartile range).
n – number; BMI – body mass index (kg/m2); HbA1c – glycated hemoglobin (%); BP – blood pressure; HDL – high-density lipoprotein (mg/dL); LDL 
– low-density lipoprotein (mg/dL); DEE – daily energy expenditure (kcal); PAL – physical activity level = total energy expenditure/resting energy 
expenditure; MVPA – moderate to vigorous physical activity (intensity >3 × resting energy expenditure) (min/day)Implementation Science 2006, 1:24 http://www.implementationscience.com/content/1/1/24
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While little is known about relapse of glycemic control,
extrapolation is possible from the practical experience
available in the obesity, alcohol and smoking literature.
Perri et al demonstrated that routine contact with provid-
ers was the only variable predictive of weight loss mainte-
nance[37]. Baum et al found that a 3 month provider
supported program resulted in greater maintenance of ini-
tial weight loss for 12 months as compared to a control
group[38]. To minimize relapse after alcohol treatment,
Marlatt recommends a behavioral maintenance package
consisting of identification of high-risk situations, train-
ing in problem solving, actual practice coping with high-
risk situations and development of cognitive coping
skills[39]. Baer's cognitive behavior model of the relapse
process in smoking puts forth that due to prior poor con-
ditioning, individuals are actively coping with situation
specific urges to smoke[40]. To prevent smoking relapse,
Baer recommends systematic but brief assessment,
encouragement, goal setting, planning for risk, reinter-
preting lapses, recommendations for lifestyle changes and
follow-up appointments. The study intervention is firmly
rooted in health behavior methods and draws from prior
experience in other diseases such as obesity, smoking and
alcohol. While maintenance of self-care behaviors is criti-
cal to prevent glycemic relapse, the "dose" of maintenance
intervention needed is unknown.
Limitations of this study include reproducibility of the
intervention and the possible differences in the routine
care received. While the intervention is outlined in this
article, it may be difficult to reproduce the problem solv-
ing skills used by the nurse practitioners in this study for
someone with no prior training. The frequency of the
intervention is varied but not the intervention content – it
is possible that another intervention would be more effec-
tive. This study was not designed to compare effectiveness
of different interventions, but to determine the optimal
frequency of an intervention that was thought to be opti-
mal based on a previously published meta-analysis[41].
The study protocol did not address how often the subjects
saw their primary care providers, the care provided by the
primary care providers or counseling given in that setting.
This study seeks to assess the efficacy of varying frequen-
cies of a highly structured nurse initiated telephonic inter-
vention for the prevention of glycemic relapse. Prevention
of glycemic relapse is a novel area in diabetes care that
remains largely unstudied. By adjusting the frequency of
the intervention, the optimal "dose" of intervention to
maintain adequate glycemic control can be determined.
This study will add to the fund of knowledge on longitu-
dinal diabetes care.
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